• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估计与 2014-2015 年美国维尔京群岛基孔肯雅热疫情相关的疾病负担和疾病经济负担。

Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands.

机构信息

Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, United States of America.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

出版信息

PLoS Negl Trop Dis. 2019 Jul 19;13(7):e0007563. doi: 10.1371/journal.pntd.0007563. eCollection 2019 Jul.

DOI:10.1371/journal.pntd.0007563
PMID:31323020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6668848/
Abstract

Chikungunya virus (CHIKV), an alphavirus that causes fever and severe polyarthralgia, swept through the Americas in 2014 with almost 2 million suspected or confirmed cases reported by April 2016. In this study, we estimate the direct medical costs, cost of lost wages due to absenteeism, and years lived with disability (YLD) associated with the 2014-2015 CHIKV outbreak in the U.S. Virgin Islands (USVI). For this analysis, we used surveillance data from the USVI Department of Health, medical cost data from three public hospitals in USVI, and data from two studies of laboratory-positive cases up to 12 months post illness. On average, employed case-patients missed 9 days of work in the 12 months following their disease onset, which resulted in an estimated cost of $15.5 million. Estimated direct healthcare costs were $2.9 million for the first 2 months and $0.6 million for 3-12 months following the outbreak. The total estimated cost associated with the outbreak ranged from $14.8 to $33.4 million (approximately 1% of gross domestic product), depending on the proportion of the population infected with symptomatic disease, degree of underreporting, and proportion of cases who were employed. The estimated YLDs associated with long-term sequelae from the CHIKV outbreak in the USVI ranged from 599-1,322. These findings highlight the significant economic burden of the recent CHIKV outbreak in the USVI and will aid policy-makers in making informed decisions about prevention and control measures for inevitable, future CHIKV outbreaks.

摘要

基孔肯雅热病毒(CHIKV)是一种引起发热和严重多发性关节炎的甲病毒,2014 年在美洲迅速传播,截至 2016 年 4 月,报告了近 200 万例疑似或确诊病例。在这项研究中,我们估计了与 2014-2015 年美国维尔京群岛(USVI)基孔肯雅热病毒爆发相关的直接医疗费用、因旷工导致的工资损失成本以及伤残损失寿命年(YLD)。在这项分析中,我们使用了 USVI 卫生部的监测数据、USVI 三家公立医院的医疗成本数据以及两项实验室阳性病例研究中发病后 12 个月的病例数据。平均而言,发病后 12 个月内,有工作的病例患者平均缺勤 9 天,导致估计损失 1550 万美元。估计直接医疗保健费用在疫情爆发的前 2 个月为 290 万美元,在第 3-12 个月为 60 万美元。与疫情相关的总估计费用在 1480 万至 3340 万美元之间(约占国内生产总值的 1%),取决于感染有症状疾病的人口比例、漏报程度以及有工作的病例比例。USVI 基孔肯雅热病毒爆发相关的长期后遗症估计 YLDs 范围在 599-1322 之间。这些发现强调了美国维尔京群岛最近基孔肯雅热病毒爆发带来的巨大经济负担,并将有助于决策者在制定预防和控制措施方面做出明智决策,以应对不可避免的未来基孔肯雅热病毒爆发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73df/6668848/f1337760a7c1/pntd.0007563.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73df/6668848/f1337760a7c1/pntd.0007563.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73df/6668848/f1337760a7c1/pntd.0007563.g001.jpg

相似文献

1
Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands.估计与 2014-2015 年美国维尔京群岛基孔肯雅热疫情相关的疾病负担和疾病经济负担。
PLoS Negl Trop Dis. 2019 Jul 19;13(7):e0007563. doi: 10.1371/journal.pntd.0007563. eCollection 2019 Jul.
2
Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.2014-2015 年美国维尔京群岛基孔肯雅病毒感染的血清阳性率和症状发病率。
Am J Trop Med Hyg. 2018 Nov;99(5):1321-1326. doi: 10.4269/ajtmh.18-0437.
3
The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015.2014 - 2015年美属维尔京群岛首次报告的基孔肯雅热疫情
Am J Trop Med Hyg. 2016 Oct 5;95(4):885-889. doi: 10.4269/ajtmh.16-0288. Epub 2016 Jul 11.
4
Economic Costs of Chikungunya Virus in Colombia.哥伦比亚基孔肯雅病毒的经济成本
Value Health Reg Issues. 2018 Dec;17:32-37. doi: 10.1016/j.vhri.2018.01.004. Epub 2018 Apr 6.
5
Knowledge and use of prevention measures for chikungunya virus among visitors - Virgin Islands National Park, 2015.2015年美属维尔京群岛国家公园游客中基孔肯雅病毒预防措施的知晓与应用情况
Travel Med Infect Dis. 2016 Sep-Oct;14(5):475-480. doi: 10.1016/j.tmaid.2016.08.011. Epub 2016 Sep 3.
6
An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014-2015.2014-2015 年美国维尔京群岛基孔肯雅热病毒爆发期间家庭和个人层面蚊虫预防方法评估。
Am J Trop Med Hyg. 2018 Mar;98(3):845-848. doi: 10.4269/ajtmh.17-0799. Epub 2018 Feb 1.
7
Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016.2014年12月至2016年2月,美属维尔京群岛与基孔肯雅病毒爆发相关的持续性关节痛
Emerg Infect Dis. 2017 Apr;23(4):673-676. doi: 10.3201/eid2304.161562.
8
Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014.2014年哥伦比亚基孔肯雅热所致疾病负担及经济成本估算
Trans R Soc Trop Med Hyg. 2015 Dec;109(12):793-802. doi: 10.1093/trstmh/trv094.
9
Entomological Investigations During Early Stages of A Chikungunya Outbreak In the United States Virgin Islands, 2014.2014年美属维尔京群岛基孔肯雅热疫情早期阶段的昆虫学调查
J Am Mosq Control Assoc. 2017 Mar;33(1):8-15. doi: 10.2987/16-6619.1.
10
Acceptability of a Chikungunya Virus Vaccine, United States Virgin Islands.基孔肯雅热病毒疫苗在美国维尔京群岛的可接受性。
Am J Trop Med Hyg. 2022 Dec 26;108(2):363-365. doi: 10.4269/ajtmh.22-0429. Print 2023 Feb 1.

引用本文的文献

1
Bioisosteric and Virtual Screening Approach to Identify Natural Inhibitors of Chikunguya alphavirus nsP3.用于鉴定基孔肯雅甲病毒nsP3天然抑制剂的生物电子等排体和虚拟筛选方法
Cell Biochem Biophys. 2025 Aug 26. doi: 10.1007/s12013-025-01849-5.
2
Cost-effectiveness of chikungunya vaccination with the live attenuated vaccine in U.S. territories.在美国属地使用减毒活疫苗接种基孔肯雅热疫苗的成本效益。
NPJ Vaccines. 2025 Jul 28;10(1):172. doi: 10.1038/s41541-025-01194-x.
3
Burden of Chikungunya Fever and Its Economic and Social Impacts Worldwide: A Systematic Review.

本文引用的文献

1
Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.2014-2015 年美国维尔京群岛基孔肯雅病毒感染的血清阳性率和症状发病率。
Am J Trop Med Hyg. 2018 Nov;99(5):1321-1326. doi: 10.4269/ajtmh.18-0437.
2
Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016.2014年12月至2016年2月,美属维尔京群岛与基孔肯雅病毒爆发相关的持续性关节痛
Emerg Infect Dis. 2017 Apr;23(4):673-676. doi: 10.3201/eid2304.161562.
3
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
全球基孔肯雅热负担及其经济和社会影响:一项系统综述
Trop Med Int Health. 2025 Sep;30(9):865-892. doi: 10.1111/tmi.70012. Epub 2025 Jul 22.
4
Dengue diagnosis and impact on clinical management: A literature review.登革热诊断及其对临床管理的影响:文献综述
PLoS Negl Trop Dis. 2025 Jun 30;19(6):e0013196. doi: 10.1371/journal.pntd.0013196. eCollection 2025 Jun.
5
One Health, many approaches: integrated vector management strategies support One Health goals.同一健康,多种方法:综合病媒管理策略助力实现同一健康目标。
Front Insect Sci. 2025 Jun 3;5:1549348. doi: 10.3389/finsc.2025.1549348. eCollection 2025.
6
Assessing chikungunya's economic burden and impact on health-related quality of life: Two systematic literature reviews.评估基孔肯雅热的经济负担及其对健康相关生活质量的影响:两项系统文献综述。
PLoS Negl Trop Dis. 2025 May 5;19(5):e0012990. doi: 10.1371/journal.pntd.0012990. eCollection 2025 May.
7
Chikungunya Replication and Infection Is Dependent upon and Alters Cellular Hexosylceramide Levels in Vero Cells.基孔肯雅病毒的复制和感染依赖于并改变了非洲绿猴肾细胞中的神经酰胺水平。
Viruses. 2025 Mar 31;17(4):509. doi: 10.3390/v17040509.
8
The global health and economic burden of chikungunya from 2011 to 2020: a model-driven analysis on the impact of an emerging vector-borne disease.2011年至2020年基孔肯雅热的全球健康和经济负担:对一种新兴媒介传播疾病影响的模型驱动分析
BMJ Glob Health. 2024 Dec 3;9(12):e016648. doi: 10.1136/bmjgh-2024-016648.
9
Distinct chikungunya virus polymerase palm subdomains contribute to viral protein accumulation and virion production.独特的基孔肯雅病毒聚合酶棕榈亚结构域有助于病毒蛋白积累和病毒粒子生成。
PLoS Pathog. 2024 Oct 14;20(10):e1011972. doi: 10.1371/journal.ppat.1011972. eCollection 2024 Oct.
10
From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine.从实验室到临床:减毒活疫苗 VLA1553/IXCHIQ 的研发。
J Travel Med. 2024 Oct 19;31(7). doi: 10.1093/jtm/taae123.
《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
4
The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015.2014 - 2015年美属维尔京群岛首次报告的基孔肯雅热疫情
Am J Trop Med Hyg. 2016 Oct 5;95(4):885-889. doi: 10.4269/ajtmh.16-0288. Epub 2016 Jul 11.
5
The global economic burden of dengue: a systematic analysis.登革热的全球经济负担:系统分析。
Lancet Infect Dis. 2016 Aug;16(8):935-41. doi: 10.1016/S1473-3099(16)00146-8. Epub 2016 Apr 16.
6
Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014.2014年哥伦比亚基孔肯雅热所致疾病负担及经济成本估算
Trans R Soc Trop Med Hyg. 2015 Dec;109(12):793-802. doi: 10.1093/trstmh/trv094.
7
Psychiatric Morbidity in Patients with Chikungunya Fever: First Report from India.基孔肯雅热患者的精神疾病发病率:来自印度的首次报告。
J Clin Diagn Res. 2015 Oct;9(10):VC01-VC03. doi: 10.7860/JCDR/2015/14569.6586. Epub 2015 Oct 1.
8
Disability weights for the Global Burden of Disease 2013 study.全球疾病负担 2013 研究的失能权重。
Lancet Glob Health. 2015 Nov;3(11):e712-23. doi: 10.1016/S2214-109X(15)00069-8.
9
Economic Burden of Dengue Virus Infection at the Household Level Among Residents of Puerto Maldonado, Peru.秘鲁马尔多纳多港居民家庭层面登革热病毒感染的经济负担
Am J Trop Med Hyg. 2015 Oct;93(4):684-90. doi: 10.4269/ajtmh.14-0755. Epub 2015 Jul 27.
10
Burden of chikungunya in Latin American countries: estimates of disability-adjusted life-years (DALY) lost in the 2014 epidemic.拉丁美洲国家基孔肯雅热的负担:2014年疫情中损失的伤残调整生命年(DALY)估计数。
Int J Infect Dis. 2015 Sep;38:60-1. doi: 10.1016/j.ijid.2015.07.015. Epub 2015 Jul 26.